NCT04627896View on ClinicalTrials.gov

Targeted Microwave Focal Therapy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

November 9, 2020

Primary Completion Date

September 30, 2022

Study Completion Date

December 30, 2022

Conditions
Prostate Cancer Stage I
Interventions
DEVICE

Katty focal therapy

Microwave ablation with TATO3 generator (Katty system) under guidance of ultrasound/mpMRI fusion image device Trinity

Trial Locations (1)

10126

A.O.U. San Giovanni Battista Molinette, Torino

Sponsors

Collaborators (1)

Koelis
All Listed Sponsors
collaborator

Koelis

INDUSTRY

lead

A.O.U. Città della Salute e della Scienza

OTHER

NCT04627896 - Targeted Microwave Focal Therapy | Biotech Hunter | Biotech Hunter